<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03591367</url>
  </required_header>
  <id_info>
    <org_study_id>MicroRNA-155 Bladder Cancer</org_study_id>
    <nct_id>NCT03591367</nct_id>
  </id_info>
  <brief_title>The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation</brief_title>
  <official_title>The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We try to assess the potential role of telomerase reverse transcriptase and MicroRNA
      (miR-155) in diagnosis of non-muscle-invasive bladder cancer and their correlation with stage
      and grade of the tumor.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Actual">May 1, 2019</completion_date>
  <primary_completion_date type="Actual">May 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>sensitivity, specificity and positive and negative predictive values of combined MicroRNA-155 And Telomerase Reverse Transcriptase In diagnosis Of Non-Muscle Invasive Bladder Cancer</measure>
    <time_frame>1 year</time_frame>
    <description>compared by standard final pathological specimen</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlation between serum Vit D and Non-Muscle Invasive Bladder Cancer</measure>
    <time_frame>1 year</time_frame>
    <description>measured serum Vit D in ng/mL.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">115</enrollment>
  <condition>Bladder Cancer</condition>
  <condition>Bladder Disease</condition>
  <condition>Bladder Neoplasm</condition>
  <condition>Micro-RNA</condition>
  <arm_group>
    <arm_group_label>Hematuria due to suspicious superficial bladder tumor</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>MicroRNAs-155 (miRNAs-155) and Human telomerase reverse transcriptase (hTERT)</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>MicroRNAs-155</intervention_name>
    <description>Quantitative analysis of cell-free miR-155 using RT-qPCR.</description>
    <arm_group_label>Hematuria due to suspicious superficial bladder tumor</arm_group_label>
    <other_name>(miRNAs-155)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Human telomerase reverse transcriptase</intervention_name>
    <description>Analysis TERT by TERT messenger RNA (mRNA)expression by reverse transcription-quantitative polymerase chain reaction.</description>
    <arm_group_label>Hematuria due to suspicious superficial bladder tumor</arm_group_label>
    <other_name>(hTERT)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women 18 years or older.

          -  Patient with hematuria suspected to be of bladder origin clinically.

          -  Willing to be participate in the study.

        Exclusion Criteria:

          -  Patient having another malignancy.

          -  Hematuria of other causes as trauma and stones
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Mosbah, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Urology and nephrology center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Urology and Nephrology Center</name>
      <address>
        <city>Mansourah</city>
        <state>Aldakahlia</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 8, 2018</study_first_submitted>
  <study_first_submitted_qc>July 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2018</study_first_posted>
  <last_update_submitted>November 1, 2019</last_update_submitted>
  <last_update_submitted_qc>November 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
    <mesh_term>Urinary Bladder Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

